Literature DB >> 35941512

Extra-abdominal Lymph Node Metastases as the First Presentation in Ovarian and Fallopian Tube Carcinomas.

Maria Lúcia Moleiro1, Alfredo Barroco Gouveia2.   

Abstract

Revision of ovarian and fallopian tube cancer presentation as extra-abdominal lymph nodes to understand the diagnostic challenges and prognostic features of these situations. Literature review in PubMed and Cochrane databases using the terms "ovarian cancer," "fallopian tube cancer," "extrapelvic lymph nodes," extra-abdominal lymph nodes," "distant lymph nodes," "initial presentation," "metastases," and "unusual presentation of ovarian cancer/unusual presentation of fallopian tube cancer" isolated and in conjunction. Articles in English were analyzed regarding revision's purpose, inclusion, and exclusion criteria and 65 were included in the final document. Statistical data was obtained with Microsoft Excel software analysis. Distant manifestations of ovarian cancer may occur through the lymphatic system and, less frequently, through hematogenous spread. These forms of spread may exist with almost no symptoms related to the primary cancer location and can justify distant disease at the initial presentation. Extra-abdominal lymph node involvement poses a clinical challenge for oncologists and oncologic gynecologists because it may occur with no or mild symptoms, and even in situations where no macroscopic disease is seen in the pelvic cavity. Histology and immunohistochemistry analyses together with a high level of suspicion are paramount to help in the diagnostic workup decisions and in finding a correct diagnosis when an extra-abdominal lymph node is the first manifested sign. Given its rarity and scarcity of information dispersed in a few case reports and small case series, further investigation is needed to understand the particularities of these tumors and their prognostic relevance.
© 2022. The Author(s), under exclusive licence to Society for Reproductive Investigation.

Entities:  

Keywords:  Extra-abdominal metastasis; Lymphatic metastasis; Ovarian cancer; Stage IV ovarian cancer

Year:  2022        PMID: 35941512     DOI: 10.1007/s43032-022-01049-z

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   2.924


  35 in total

1.  The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.

Authors:  Fabiola Medeiros; Michael G Muto; Yonghee Lee; Julia A Elvin; Michael J Callahan; Colleen Feltmate; Judy E Garber; Daniel W Cramer; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2006-02       Impact factor: 6.394

Review 2.  Computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with ovarian cancer: a meta-analysis.

Authors:  Ying Yuan; Zhao-Xiang Gu; Xiao-Feng Tao; Shi-Yuan Liu
Journal:  Eur J Radiol       Date:  2011-02-23       Impact factor: 3.528

3.  FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread.

Authors:  Johanna Hynninen; Annika Auranen; Olli Carpén; Kirsti Dean; Marko Seppänen; Jukka Kemppainen; Maija Lavonius; Irina Lisinen; Johanna Virtanen; Seija Grénman
Journal:  Gynecol Oncol       Date:  2012-04-24       Impact factor: 5.482

4.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

5.  Diagnosis and staging of primary ovarian cancer: correlation between PET/CT, Doppler US, and CT or MRI.

Authors:  Eun Ji Nam; Mi Jin Yun; Young Taik Oh; Jae Wook Kim; Jae Hoon Kim; Sunghoon Kim; Yong Wook Jung; Sang Wun Kim; Young Tae Kim
Journal:  Gynecol Oncol       Date:  2009-11-18       Impact factor: 5.482

Review 6.  Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.

Authors:  Tsz-Lun Yeung; Cecilia S Leung; Kay-Pong Yip; Chi Lam Au Yeung; Stephen T C Wong; Samuel C Mok
Journal:  Am J Physiol Cell Physiol       Date:  2015-07-29       Impact factor: 4.249

7.  Metastatic patterns in histologic variants of ovarian cancer. An autopsy study.

Authors:  P G Rose; M S Piver; Y Tsukada; T S Lau
Journal:  Cancer       Date:  1989-10-01       Impact factor: 6.860

8.  Does the use of diagnostic PET/CT cause stage migration in patients with primary advanced ovarian cancer?

Authors:  S Risum; C Høgdall; A Loft; A K Berthelsen; E Høgdall; L Nedergaard; L Lundvall; S A Engelholm
Journal:  Gynecol Oncol       Date:  2009-12-29       Impact factor: 5.482

9.  Ovarian, uterine, and cervical cancer patients with distant metastases at diagnosis: most common locations and outcomes.

Authors:  Austin B Gardner; Lindsey M Charo; Amandeep K Mann; Daniel S Kapp; Ramez N Eskander; John K Chan
Journal:  Clin Exp Metastasis       Date:  2019-11-22       Impact factor: 5.150

10.  Distant metastases in ovarian carcinoma.

Authors:  G Cormio; C Rossi; A Cazzolla; L Resta; G Loverro; P Greco; L Selvaggi
Journal:  Int J Gynecol Cancer       Date:  2003 Mar-Apr       Impact factor: 3.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.